DaVita Reports Q3 2026 Growth Driven by Integrated Kidney Care and Margin Improvements
DaVita Inc. (DVA) reported strong third-quarter 2026 financial results, with total revenues rising to $3.578 billion from $3.42 billion in the prior year. The company's adjusted earnings per share reached $3.82, supported by robust operational performance and strategic share repurchases totaling $111 million during the quarter. Key growth drivers included outperformance in the Integrated Kidney Care (IKC) segment and improved margins within Latin American operations. While patient care costs rose 2.4% due to labor and medical supply expenses, management raised its full-year adjusted EPS guidance to a range of $14.30 to $15.20, reflecting confidence in the company's trajectory despite higher-than-forecasted technology investments.
Tickers: $DVA
Topics: earnings report eps guidance operating income revenue growth share repurchases
Read the full article at Motley Fool
Part of the story Black Hills Corporation Reports Q3 2026 Earnings Growth Driven by Rate Increases and New Generation Projects (9 articles)